Evidence map›Paper›PMID 33571537›Full record

SynthesisThe Journal of allergy and clinical immunology2021

Using data from food challenges to inform management of consumers with food allergy: A systematic review with individual participant data meta-analysis.

Nandinee Patel, Daniel C Adelman, Katherine Anagnostou, Joseph L Baumert, W Marty Blom, Dianne E Campbell, R Sharon Chinthrajah, E N Clare Mills, Bushra Javed, Natasha Purington and 5 more

Open access · hybridAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in The Journal of allergy and clinical immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 4 pooled it
6.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 4 syntheses or guidelines pooled it, 64 citations in OpenAlex.

  1. Hospital-Based Food Challenges for the Diagnosis of Food Allergy-A BSACI Clinical Practice Statement.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2026
    Guideline
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Review
  7. Article
  8. Article
  9. Evolving Food Allergy Clinical Trials to Become More Patient-Centered.The journal of allergy and clinical immunology. In practice · 2025
    Review
  10. Article
  11. Article
  12. Precautionary Allergen Labeling: Avoidance for All?Current allergy and asthma reports · 2024
    Review
  13. Feast for thought: A comprehensive review of food allergy 2021-2023.The Journal of allergy and clinical immunology · 2024
    Review
  14. Article
  15. Article
  16. Article
  17. Will Oral Food Challenges Still Be Part of Allergy Care in 10 Years' Time?The journal of allergy and clinical immunology. In practice · 2023
    Review
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 5 countries.

Nandinee PatelNational Heart and Lung Institute, Imperial College London, London, United Kingdom.
Daniel C AdelmanAimmune Therapeutics, Brisbane, Calif.
Katherine AnagnostouSection of Allergy and Immunology, Baylor College of Medicine, Houston, Tex; Section of Allergy and Immunology, Department of Pediatrics, Texas Children's Hospital, Houston, Tex.
Joseph L BaumertFood Allergy Research and Resource Program, University of Nebraska, Lincoln, Neb.
W Marty BlomThe Netherlands Organisation of Applied Scientific Research, Utrecht, The Netherlands.
Dianne E CampbellDepartment of Allergy and Immunology, The Children's Hospital at Westmead, Sydney, Australia; DBV Technologies, Montrouge, France.
R Sharon ChinthrajahSean N. Parker Center for Allergy and Asthma Research, Stanford, Calif; Division of Pulmonary, Allergy, and Critical Care Medicine, Stanford University, Stanford, Calif.
E N Clare MillsDivision of Infection, Immunity and Respiratory Medicine, Manchester Institute of Biotechnology, University of Manchester, Manchester, United Kingdom.
Bushra JavedDivision of Infection, Immunity and Respiratory Medicine, Manchester Institute of Biotechnology, University of Manchester, Manchester, United Kingdom.
Natasha PuringtonDepartment of Medicine, Quantitative Sciences Unit, Stanford University School of Medicine, Stanford, Calif.
Benjamin C RemingtonFood Allergy Research and Resource Program, University of Nebraska, Lincoln, Neb.
Hugh A SampsonDBV Technologies, Montrouge, France; Division of Pediatric Allergy and Immunology, Icahn School of Medicine at Mount Sinai, New York, NY.
Alexander D SmithAimmune Therapeutics, Brisbane, Calif.
Ross A R YarhamFood Standards Agency, London, United Kingdom.
Paul J TurnerNational Heart and Lung Institute, Imperial College London, London, United Kingdom. Electronic address: p.turner@imperial.ac.uk.
DBV Technologies (France) · FRImperial College London · GBStanford University · USUniversity of Manchester · GBUniversity of Nebraska–Lincoln · USFood Standards Agency · GBNetherlands Organisation for Applied Scientific Research · NLTexas Children's Hospital · US

Funding

Department of HealthMedical Research Council MR/K010468/1
6 · The paper itself

Abstract

backgroundEliciting doses (EDs) (eg, ED

objectiveOur aim was to determine (1) the rate of anaphylaxis in response to low-level peanut exposure and (2) the reproducibility of reaction thresholds (and anaphylaxis) at food challenge.

methodsWe conducted a systematic review and individual participant data meta-analysis of studies that reported at least 50 individuals with peanut allergy reacting to peanut at double-blind, placebo-controlled food challenge (DBPCFC) and were published between January 2010 and September 2020. Risk of bias was assessed by using National Institute for Clinical Excellence methodologic checklists.

resultsA total of 19 studies were included (covering a total of 3151 participants, 534 of whom subsequently underwent further peanut challenge). At individual participant data meta-analysis, 4.5% (95% CI, 1.9% to 10.1%) of individuals reacted to 5 mg or less of peanut protein with anaphylaxis (moderate heterogeneity [I

conclusionAround 5% of individuals reacting to an ED

Indexed as

Desensitization, ImmunologicAdministration, OralAllergensAnaphylaxisAnimalsArachisFoodFood HypersensitivityHumansPeanut HypersensitivityRecurrenceReproducibility of ResultsAllergensEliciting doseoral food challengepeanut allergyprecautionary allergen labelingthresholds

Identifiers

PMID33571537
PMCPMC8168954
OpenAlexW3127512968

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.